Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1721972

registered interest
date	18/07/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pancreatic Cancer: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will take steps to improve early diagnosis rates for pancreatic cancer.
tabling member constituency	South Holland and The Deepings
tabling member printed	Sir John Hayes
uin	598
answer	answer is ministerial correction date of answer 23/07/2024 answer text <p>Pancreatic cancer is the deadliest common cancer, and earlier diagnosis is imperative in improving treatment options and survivorship. The Government is committed to improving early diagnosis rates for all cancers, and as part of this, supports the NHS Long Term Plan, which includes a principal priority to increase the proportion of cancers diagnosed at stages 1 and 2 to 75% by 2028. This threshold is key to improving outcomes and survival rates for all types of cancer, including pancreatic.</p><p>We know that pancreatic cancer is difficult to diagnose due to the non-specific nature of its symptoms. To improve diagnosis and outcomes, NHS England is delivering a range of interventions including implementing non-specific symptom pathways for patients who have symptoms that do not align to a tumour type, as is often the case with pancreatic cancer. 96 pathways are in place, and more are being introduced. NHS England is also increasing general practice direct access to diagnostic tests, alongside providing a route into pancreatic cancer surveillance for those at inherited high-risk, to identify lesions before they develop into cancer, and diagnose cancers sooner.</p><p>Additionally, NHS England’s Getting it Right First Time programme has appointed a team of five specialist clinicians to lead a national review into services for pancreatic cancer patients in England. The new workstream supports the delivery of the Optimal Care Pathway, a Pancreatic Cancer UK-led initiative which has brought together 300 health professionals and people affected to agree on how standards of diagnosis, treatment, and care of those with pancreatic cancer and their families can be improved.</p> answering member constituency Gorton and Denton answering member printed Andrew Gwynne question first answered 23/07/2024 15:20:25 answering member 1506 label Biography information for Andrew Gwynne
tabling member	350 label Biography information for Sir John Hayes

1721993

registered interest
date	18/07/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of making pre-exposure prophylaxis (PrEP) available (a) in pharmacies and (b) from an online service.
tabling member constituency	Brighton Pavilion
tabling member printed	Siân Berry
uin	782
answer	answer is ministerial correction date of answer 23/07/2024 answer text <p>Human immunodeficiency virus (HIV) is a priority for the Government, and we will commission a new plan to end new HIV transmissions within England by 2030. As part of our work in developing a new plan, we will explore options for ensuring equity and equal access to pre-exposure prophylaxis (PrEP) for all communities, including those across different risk, demographic, and geographic groups. We will also explore opportunities to deliver PrEP in settings outside of sexual health services, to improve access and equity, including considering online PrEP provision and PrEP in pharmacies.</p> answering member constituency Gorton and Denton answering member printed Andrew Gwynne grouped question UIN 788 question first answered 23/07/2024 09:28:11 answering member 1506 label Biography information for Andrew Gwynne
tabling member	5314

1721994

registered interest
date	18/07/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure communities have equal access to pre-exposure prophylaxis (PrEP) across different (a) risk, (b) demographic and (c) geographic groups.
tabling member constituency	Brighton Pavilion
tabling member printed	Siân Berry
uin	788
answer	answer is ministerial correction date of answer 23/07/2024 answer text <p>Human immunodeficiency virus (HIV) is a priority for the Government, and we will commission a new plan to end new HIV transmissions within England by 2030. As part of our work in developing a new plan, we will explore options for ensuring equity and equal access to pre-exposure prophylaxis (PrEP) for all communities, including those across different risk, demographic, and geographic groups. We will also explore opportunities to deliver PrEP in settings outside of sexual health services, to improve access and equity, including considering online PrEP provision and PrEP in pharmacies.</p> answering member constituency Gorton and Denton answering member printed Andrew Gwynne grouped question UIN 782 question first answered 23/07/2024 09:28:11 answering member 1506 label Biography information for Andrew Gwynne
tabling member	5314

1721243

registered interest
date	17/07/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Non-surgical Cosmetic Procedures: Medical Treatments Abroad
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of the cost to the NHS of cosmetic medical procedures conducted overseas and any subsequent complications; and what plans they have, if any, to limit or control the advertising of such procedures.
tabling member printed	Baroness Bennett of Manor Castle
uin	HL17
answer	answer is ministerial correction date of answer 23/07/2024 answer text <p>The Department does not have data on the overall costs to the National Health Service of treating complications from cosmetic and medical procedures conducted overseas. With regards to the advertising of cosmetic procedures conducted overseas, the Department continues to work closely with the Foreign, Commonwealth and Development Office and with the Advertising Standards Authority (ASA), with the ASA taking enforcement activity against any company which contravenes United Kingdom advertising standards.</p> answering member printed Baroness Merron question first answered 23/07/2024 10:22:38 answering member 347 label Biography information for Baroness Merron
tabling member	4719 label Biography information for Baroness Bennett of Manor Castle

1721330

registered interest
date	17/07/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Vaccine Damage Payment Scheme
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many applications were made under the Vaccine Damage Payment Scheme for redress arising from the administration of covid-19 vaccines as at 1 July 2024; and how many and what proportion of those applications were (a) decided, (b) successful and (c) rejected on the grounds that the 60% disability threshold had not been reached.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	11
answer	answer is ministerial correction date of answer 22/07/2024 answer text <p>As of 1 July 2024, the NHS Business Services Authority had received 14,088 claims to the Vaccine Damage Payment Scheme (VDPS) relating to COVID-19. Following medical assessment, 6,850 claims, or 48.6% of the total number of claims, had received an initial outcome, with 181 claims, or 1.3%, being successful and 6,062 claims, 45.1%, being unsuccessful. A further 607 claims, or 4.3%, were found invalid, due to being either outside the scope of the VDPS or a duplicate claim. Of the 6,062 unsuccessful claims, 360 claims, or 2.6%, were rejected on the grounds that the 60% disability threshold had not been reached.</p> answering member constituency Gorton and Denton answering member printed Andrew Gwynne question first answered 22/07/2024 08:51:44 answering member 1506 label Biography information for Andrew Gwynne
tabling member	242 label Biography information for Sir Christopher Chope

1721344

registered interest
date	17/07/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Liver Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to help raise awareness of liver disease.
tabling member constituency	South Holland and The Deepings
tabling member printed	Sir John Hayes
uin	22
answer	answer is ministerial correction date of answer 23/07/2024 answer text <p>Awareness of liver disease can be raised by providing information to the public and by supporting health and care professionals to discuss liver disease with their patients. The NHS.UK website provides the public with essential information on types of liver disease, their possible causes, symptoms, treatment, and prevention. Further information is available at the following link:</p><p><a href="https://www.nhs.uk/conditions/liver-disease/" target="_blank">https://www.nhs.uk/conditions/liver-disease/</a></p><p>In May 2022, the Department published guidance for health and care professionals on promoting awareness of liver disease in professional practice. Further information on this guidance is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/liver-disease-applying-all-our-health/liver-disease-applying-all-our-health#promoting-awareness-of-liver-disease-in-your-professional-practice" target="_blank">https://www.gov.uk/government/publications/liver-disease-applying-all-our-health/liver-disease-applying-all-our-health#promoting-awareness-of-liver-disease-in-your-professional-practice</a></p><p>Furthermore, the United Kingdom’s clinical guidelines for alcohol treatment, published by the Office for Health Improvement and Disparities for consultation in October 2023, contain clinical guidance and advice for professionals on the early identification of liver disease among people with alcohol use disorders, and on the treatment of alcohol use disorders in people diagnosed with liver disease. Further information on the guidance is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/liver-disease-applying-all-our-health/liver-disease-applying-all-our-health" target="_blank">https://www.gov.uk/government/publications/liver-disease-applying-all-our-health/liver-disease-applying-all-our-health</a></p><p>The Department is currently reviewing these guidelines following a consultation.</p> answering member constituency Gorton and Denton answering member printed Andrew Gwynne question first answered 23/07/2024 15:24:25 answering member 1506 label Biography information for Andrew Gwynne
tabling member	350 label Biography information for Sir John Hayes

1721362

registered interest
date	17/07/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Meat Products: Salt
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the implications for his policies of the volume of salt in processed meat.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	85
answer	answer is ministerial correction date of answer 23/07/2024 answer text <p>Processed meats are generally high in salt and, on average, meat and meat products contribute approximately 27% of salt intakes. A high intake of salt increases the risk of high blood pressure which, in turn, increases the risk of heart disease or a stroke. Reducing salt in foods by 1 gram per day, for example, could prevent 1,500 premature deaths each year, saving the National Health Service over £140 million.</p><p>To reduce salt levels in foods, the voluntary salt reduction programme sets targets for different food and drink product categories that contribute to salt intakes, including processed meats such as ham, bacon, and sausages. Businesses across all sectors of the food industry are required to work towards these targets. Separate targets on a meal basis have been set for the out of home sector, which includes processed meats where appropriate.</p><p>The targets were first set in 2006 and have been revised downwards five times to continually reduce salt content, with the most recent targets published in 2020. Businesses are expected to achieve the latest levels set by the end of 2024.</p><p>The most recent assessment of industry progress suggests that small reductions in salt content were seen in some meat products between 2017 and 2018. Salt intakes decreased from 9.38 grams to 8.4 grams a day between 2000 and 2018/19.</p> answering member constituency Gorton and Denton answering member printed Andrew Gwynne question first answered 23/07/2024 08:02:16 answering member 1506 label Biography information for Andrew Gwynne
tabling member	4131 label Biography information for Jim Shannon

1721439

registered interest
date	17/07/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Shingles: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he make an assessment of the effectiveness of the roll-out of the shingles vaccine.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	103
answer	answer is ministerial correction date of answer 23/07/2024 answer text <p>From September 2023, the routine shingles vaccination programme changed from the Zostavax vaccine to the more effective Shingrix vaccine, to better protect individuals from the effects of shingles, provide better clinical outcomes and reduce pressures on the health system. A phased expansion of the routine eligible cohort from people aged 70 years old to those aged 60 years old also began in September 2023, as Shingrix provides a substantially superior and longer duration of protection.</p><p>Uptake is in line with where we expect it to be at this stage. Data from approximately 40% of general practices across England showed that uptake of the first dose of Shingrix in adults turning 65 years old in the first quarter of the programme roll-out was 25.1%. The data also showed that uptake of the first dose of Shingrix in adults turning 70 years old in the same period was 34.2%. This is comparable to uptake of Zostavax in those aged 70 years old in the early part of the programme roll-out, and is anticipated to increase over time.</p><p>Published data is cumulative and there is a time lag because, whilst the data covers all eligible individuals that quarter, individuals whose birthday is at the end of a quarter have far less time to receive the vaccine than those at the beginning and may then be picked up in the next or subsequent quarters. Individuals become eligible when they turn 65 or 70 years old but then remain eligible until aged 80 years old and may not come forward or be called to receive the vaccine immediately. This is accounted for in planning the programme and in relation to vaccine supply.</p><p>With the new vaccine schedule, patients now need two doses of the shingles vaccine. Ensuring patients receive both doses is vital to making sure patients receive the full benefits. To ensure patients come in for their second dose, which is due from six to 12 months following their first dose, NHS England is encouraging local systems to let patients know when and where they will receive their second dose to increase follow-through, send reminders, promote the programme and frame the overall goal in terms of having maximum protection by receiving both doses. A consistent offer and sustained communication to the public is key to achieving uptake of both first and second dose to all those eligible in line with the Joint Committee on Vaccination and Immunisation’s advice.</p> answering member constituency Gorton and Denton answering member printed Andrew Gwynne question first answered 23/07/2024 09:34:34 answering member 1506 label Biography information for Andrew Gwynne
tabling member	4471 label Biography information for Rachael Maskell

1721589

registered interest
date	17/07/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospital Beds: Somerset
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many hospital beds there were in Somerset (a) in 2015 and (b) 2024.
tabling member constituency	Glastonbury and Somerton
tabling member printed	Sarah Dyke
uin	304
answer	answer is ministerial correction date of answer 22/07/2024 answer text <p>The latest published data shows a total of 1,438 hospital beds in Somerset, in quarter four of 2023/24. This compares to a total of 1,374 hospital beds reported by National Health Service trusts in quarter four of 2014/15.</p><p>Data on NHS bed numbers is published by NHS England, and is available at the following link:</p><p><a href="https://www.england.nhs.uk/statistics/statistical-work-areas/bed-availability-and-occupancy/bed-data-overnight/" target="_blank">https://www.england.nhs.uk/statistics/statistical-work-areas/bed-availability-and-occupancy/bed-data-overnight/</a></p> answering member constituency Bristol South answering member printed Karin Smyth question first answered 22/07/2024 15:29:59 answering member 4444 label Biography information for Karin Smyth
tabling member	4995 label Biography information for Sarah Dyke

1721612

registered interest
date	17/07/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Sodium Valproate and Surgical Mesh Implants
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when his Department plans to respond to the recommendations of the report by the Patient Safety Commissioner entitled The Hughes report, published on 7 February 2024.
tabling member constituency	Chesham and Amersham
tabling member printed	Sarah Green
uin	327
answer	answer is ministerial correction date of answer 23/07/2024 answer text <p>The Government will consider the recommendations of The Hughes Report and the relevant Minister is due to meet with the Patient Safety Commissioner this week.</p><p>To prevent future harm, the Medicines and Healthcare products Regulatory Agency, NHS England, and others have taken action to strengthen oversight of valproate prescribing. For example, nine specialist mesh centres are in operation across England, ensuring that women with complications of mesh inserted for urinary incontinence and vaginal prolapse get the right support in every region, and we have maintained the national pause on the use of pelvic mesh, which has been in place since July 2018.</p> answering member constituency Gorton and Denton answering member printed Andrew Gwynne question first answered 23/07/2024 15:15:45 answering member 1506 label Biography information for Andrew Gwynne previous answer version 152 answering member constituency Gorton and Denton answering member printed Andrew Gwynne answering member 1506 label Biography information for Andrew Gwynne
tabling member	4918 label Biography information for Sarah Green